» Authors » S Paolacci

S Paolacci

Explore the profile of S Paolacci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 171
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiani A, Anpilogov K, Dhuli K, Paolacci S, Benedetti S, Manara E, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):101-107. PMID: 34890040
Objective: The aim of the study was to show the importance of developing techniques that could exploit the potential of bacteriophages as therapeutics or food supplements. Materials And Methods: PubMed...
2.
Paolacci S, Kiani A, Shree P, Tripathi D, Tripathi Y, Tripathi P, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):90-100. PMID: 34890039
Objective: The aim of the study was to show the effect that two naturally occurring compounds, a cyclodextrin and hydroxytyrosol, can have on the entry of SARS-CoV-2 into human cells....
3.
Paolacci S, Ergoren M, De Forni D, Manara E, Poddesu B, Cugia G, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):81-89. PMID: 34890038
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the current pandemic of coronavirus disease 2019 (COVID-19). This virus attacks cells of the airway epithelium...
4.
Naureen Z, Capodicasa N, Paolacci S, Anpilogov K, Dautaj A, Dhuli K, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):74-80. PMID: 34890037
Objective: Face masks help contain the aerosol-mediated transmission of infectious viral particles released from individuals via cough and sneezes. However, the prolonged use of face masks has raised concerns regarding...
5.
Naureen Z, Dautaj A, Nodari S, Fioretti F, Dhuli K, Anpilogov K, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):67-73. PMID: 34890036
A vast majority of COVID-19 patients experience fatigue, extreme tiredness and symptoms that persist beyond the active phase of the disease. This condition is called post-COVID syndrome. The mechanisms by...
6.
Bhusan Tripathi Y, Pandey N, Mishra P, Tripathi P, Coatto M, Anpilogov K, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):56-66. PMID: 34890035
Objective: The aim of our study was to evaluate in vivo, in a mouse tail model of lymphedema, the effects of a dietary supplement, Garlive®, based on hydroxytyrosol from olive...
7.
Kiani A, Paolacci S, Amato B, Mattassi R, Tassi V, Falsini B, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):49-55. PMID: 34890034
Objective: The amniotic fluid contains a large population of stem keratinocytes demonstrating minimal immunological rejection. Recent evidence suggests that stem cells from the amniotic fluid can be employed in the...
8.
Catelani Cardoso C, Miraldi E, Ceccarini M, Naureen Z, Baini G, Manara E, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):43-48. PMID: 34890033
Objective: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective...
9.
Dhuli K, Ceccarini M, Precone V, Maltese P, Bonetti G, Paolacci S, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):33-42. PMID: 34890032
Objective: Lymphedema is a debilitating disease and may be a comorbidity of obesity. New molecules have been investigated for the treatment of lymphedema; one of the most promising molecules is...
10.
Kiani A, Mor M, Bernini A, Fulcheri E, Herbst K, Buffelli F, et al.
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(1 Suppl):23-32. PMID: 34890031
Adipocytes express various enzymes, such as aldo-keto reductases (AKR1C), 11β-hydroxysteroid dehydrogenase (11β-HSD), aromatase, 5α-reductases, 3β-HSD, and 17β-HSDs involved in steroid hormone metabolism in adipose tissues. Increased activity of AKR1C enzymes...